Sorrento Therapeutics Shanghai Co., Ltd.
Sorrento Therapeutics Shanghai Co., Ltd., a subsidiary of Sorrento Therapeutics, Inc., is a prominent player in the biopharmaceutical industry, headquartered in the United States. Established in 2006, the company has made significant strides in the development of innovative therapies, particularly in oncology and immunology. With major operations in Shanghai, Sorrento Therapeutics focuses on advancing its proprietary antibody and cell therapy platforms, which are designed to address unmet medical needs.
The company is renowned for its unique approach to drug development, leveraging cutting-edge technologies to create targeted therapies. Sorrento Therapeutics has achieved notable milestones, including successful clinical trials and strategic partnerships that enhance its market position. As a leader in the biopharmaceutical sector, Sorrento Therapeutics continues to push the boundaries of science, aiming to deliver transformative treatments to patients worldwide.
Part of the Sustainability team at Sorrento Therapeutics Shanghai Co., Ltd.?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Reported emissions
No reported emissions data is available for Sorrento Therapeutics Shanghai Co., Ltd. yet.
Sorrento Therapeutics Shanghai Co., Ltd.'s reported carbon emissions
Sorrento Therapeutics Shanghai Co., Ltd., a subsidiary of Sorrento Therapeutics, Inc., currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures. Consequently, there are no recorded emissions in kg CO2e for the most recent year or any previous years.
As a current subsidiary, Sorrento Therapeutics Shanghai may inherit climate commitments and initiatives from its parent company, Sorrento Therapeutics, Inc. However, no specific reduction targets or climate pledges have been identified for Sorrento Therapeutics Shanghai. The company does not appear to have set Science-Based Targets Initiative (SBTi) reduction targets or any documented climate initiatives.
In the context of the industry, it is essential for companies like Sorrento Therapeutics Shanghai to establish clear climate commitments and emissions reduction strategies to align with global sustainability goals. The lack of reported emissions data and reduction initiatives highlights an opportunity for the company to enhance its environmental accountability and contribute to broader climate action efforts.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Sorrento Therapeutics Shanghai Co., Ltd.’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Sorrento Therapeutics Shanghai Co., Ltd. yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsNo peer comparison is available for Sorrento Therapeutics Shanghai Co., Ltd. yet.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project